If I had known the risk in 2004, I would have never taken Citalopram. It’s good to see that manufacturers have been adding the info to their leaflets (however obliquely it may be worded) following a 2019 recommendation by EMA.
But that’s not helping anyone affected by PSSD and honestly, with plenty of other options being available, the medication is just too unsafe to be sold at this point, IMHO.
If I had known the risk in 2004, I would have never taken Citalopram. It’s good to see that manufacturers have been adding the info to their leaflets (however obliquely it may be worded) following a 2019 recommendation by EMA.
But that’s not helping anyone affected by PSSD and honestly, with plenty of other options being available, the medication is just too unsafe to be sold at this point, IMHO.